Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Conditions: Chordoma; Chemotherapy Effect Interventions: Drug: camrelizumab and apatinib Sponsors: Xuanwu Hospital, Beijing Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Multi-parametric Imaging in Personalized Radiotherapy
Condition: Skull Base Chordoma Intervention: Diagnostic Test: diffusion MRI sequences Sponsors: CNAO National Center of Oncological Hadrontherapy; Dept. of Electronics, Informatics, Bioengineering, Politecnico di Milano, Italy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials
